GALACTOSE-INDUCED RETINAL MICROANGIOPATHY IN RATS

被引:0
|
作者
KERN, TS
ENGERMAN, RL
机构
关键词
RETINOPATHY; GALACTOSEMIA; RAT; POLYOL PATHWAY; ALDOSE REDUCTASE INHIBITOR;
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose. The suitability of the galactose-fed rat as a model of diabetic retinopathy was examined in nondiabetic rats fed diets enriched with either 30% or 50% galactose for up to 2 years. Methods. Retinal capillaries were examined by light and electron microscopy, and the prevalence or severity of diabetic-like lesions was quantitated. Results. Histologic evaluation of trypsin digests of retina revealed significantly greater than normal frequencies of pericyte ghosts and acellular capillaries at both 15 and 23 months receiving a 50% galactose diet. Similar lesions were observed in rats receiving a 30% galactose diet for 23 months. Capillary basement membrane thickening, dilated hypercellular capillaries (or intra-retinal microvascular abnormalities), and foci of vascular cells appeared in rats fed 50% galactose, but saccular microaneurysms characteristic of retinopathy in diabetic patients, diabetic dogs, and experimentally galactosemic dogs were not observed. Administration of the aldose reductase inhibitor, Sorbinil, to rats fed 50% galactose resulted in a significant inhibition of cataract and of galactitol accumulation in nerve and brood (by more that 90%) and retina (by 62%), but did not inhibit development of the retinal microvascular lesions. Conclusions. Two years of galactosemia in rats seems to reproduce only a portion of the lesions characteristic of diabetic retinopathy in patients or dogs. Nevertheless, lesions characteristic of at least the early stages of retinopathy clearly do develop in this galactosemic rat model, and are not restrained by inhibition of retinal polyol accumulation by 62%. Invest Ophthalmol Vis Sci. 1995;36:490-496.
引用
收藏
页码:490 / 496
页数:7
相关论文
共 50 条
  • [31] EFFECTS OF DARKNESS AND OCULAR PIGMENTATION ON GALACTOSE-INDUCED CATARACT FORMATION AND OCULAR LIPID-PEROXIDATION IN RATS
    RIBAYAMERCADO, JD
    BANKSON, DD
    TOM, A
    GERSHOFF, SN
    RUSSELL, RM
    FEDERATION PROCEEDINGS, 1986, 45 (03) : 577 - 577
  • [32] Cell growth of rat lens epithelium in galactose-induced cataracts
    Kubo, E
    Takayanagi, K
    Tsuzuki, S
    Takahashi, Y
    Akagi, Y
    ACTA HISTOCHEMICA ET CYTOCHEMICA, 1997, 30 (03) : 243 - 249
  • [33] Tocotrienol delays onset and progression of galactose-induced cataract in rat
    Nasir, Nurul Alimah Abdul
    Agarwal, Renu
    Tripathy, Minaketan
    Alyautdin, Renad
    Ismail, Nafeeza Mohd
    ACTA PHARMACOLOGICA SINICA, 2013, 34 : 147 - 147
  • [34] RAT LENS PROSTAGLANDIN BIOSYNTHESIS DURING GALACTOSE-INDUCED CATARACTOGENESIS
    KEETING, PE
    DONG, DS
    LYSZ, TW
    FU, SCJ
    EXPERIMENTAL EYE RESEARCH, 1986, 43 (06) : 1103 - 1110
  • [35] Laser Raman Spectrometry Study on Experimental Galactose-induced Cataract
    Shufang Dai Shaowen Qi Lingzhi Zhang Caixia Bai Tongwen Ni Xiaoying DengDepartment of Ophthalmology The First Affiliated Hospital Lan Zhou Medical College Lanzhou China
    眼科学报, 1995, (03) : 143 - 146
  • [36] Esculetin and idebenone ameliorate galactose-induced cataract in a rat model
    Sadik, Nermin Abdel Hamid
    El-Boghdady, Noha Ahmed
    Omar, Nesreen Nabil
    Abd Al-Hamid, Hager
    JOURNAL OF FOOD BIOCHEMISTRY, 2020, 44 (07)
  • [37] DOSE-RESPONSE CHARACTERISTICS OF GALACTOSE-INDUCED CATARACT IN THE RAT
    MEYDANI, M
    MARTIN, A
    SASTRE, J
    SMITH, D
    DALLAL, G
    TAYLOR, A
    BLUMBERG, J
    OPHTHALMIC RESEARCH, 1994, 26 (06) : 368 - 374
  • [39] Microangiopathy Associated with Drug-Induced Retinal Degeneration in Rats and Mice
    Matsuura, Tetsuro
    Ozaki, Kiyokazu
    Sano, Tomoya
    Narama, Isao
    TOXICOLOGIC PATHOLOGY, 2009, 37 (01) : 140 - 140
  • [40] The roles of galactitol, galactose-1-phosphate, and phosphoglucomutase in galactose-induced toxicity in Saccharomyces cerevisiae
    de Jongh, Willem A.
    Bro, Christoffer
    Ostergaard, Simon
    Regenberg, Birgitte
    Olsson, Lisbeth
    Nielsen, Jens
    BIOTECHNOLOGY AND BIOENGINEERING, 2008, 101 (02) : 317 - 326